X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Bajaj Finance with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAJAJ FINANCE vs INDOCO REMEDIES - Comparison Results

BAJAJ FINANCE    Change

Established in 1987, Bajaj Finance Ltd is a subsidiary of Bajaj Finserv Ltd, the financial services arm of the Bajaj Group. In the early days, Bajaj Finance provided loans for two and three-wheelers manufactured by Bajaj Auto Ltd. Over the years, the... More

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAJAJ FINANCE INDOCO REMEDIES BAJAJ FINANCE/
INDOCO REMEDIES
 
P/E (TTM) x 44.6 37.4 119.3% View Chart
P/BV x 7.8 2.9 265.8% View Chart
Dividend Yield % 0.2 0.8 21.6%  

Financials

 BAJAJ FINANCE   INDOCO REMEDIES
EQUITY SHARE DATA
    BAJAJ FINANCE
Mar-18
INDOCO REMEDIES
Mar-17
BAJAJ FINANCE/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs1,989360 551.9%   
Low Rs1,153249 462.7%   
Sales per share (Unadj.) Rs1,168.6119.0 981.8%  
Earnings per share (Unadj.) Rs232.58.4 2,779.6%  
Cash flow per share (Unadj.) Rs241.315.2 1,584.6%  
Dividends per share (Unadj.) Rs4.001.60 250.0%  
Dividend yield (eoy) %0.30.5 48.5%  
Book value per share (Unadj.) Rs1,438.470.7 2,034.3%  
Shares outstanding (eoy) m115.0392.15 124.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.32.6 52.5%   
Avg P/E ratio x6.836.4 18.5%  
P/CF ratio (eoy) x6.520.0 32.5%  
Price / Book Value ratio x1.14.3 25.3%  
Dividend payout %1.719.1 9.0%   
Avg Mkt Cap Rs m180,68928,083 643.4%   
No. of employees `00015.36.0 252.9%   
Total wages/salary Rs m14,1962,167 655.2%   
Avg. sales/employee Rs Th8,805.21,817.0 484.6%   
Avg. wages/employee Rs Th929.9359.0 259.1%   
Avg. net profit/employee Rs Th1,751.7127.7 1,371.9%   
INCOME DATA
Net Sales Rs m134,42010,968 1,225.6%  
Other income Rs m23940 601.3%   
Total revenues Rs m134,65911,007 1,223.4%   
Gross profit Rs m88,0871,565 5,630.0%  
Depreciation Rs m1,021633 161.3%   
Interest Rs m46,34362 74,626.9%   
Profit before tax Rs m40,962909 4,504.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m14,221139 10,253.0%   
Profit after tax Rs m26,741771 3,469.7%  
Gross profit margin %65.514.3 459.4%  
Effective tax rate %34.715.3 227.6%   
Net profit margin %19.97.0 283.1%  
BALANCE SHEET DATA
Current assets Rs m377,8065,725 6,599.5%   
Current liabilities Rs m227,4585,454 4,170.4%   
Net working cap to sales %111.82.5 4,531.7%  
Current ratio x1.71.0 158.2%  
Inventory Days Days062 0.0%  
Debtors Days Days93272 1,298.8%  
Net fixed assets Rs m4,6705,307 88.0%   
Share capital Rs m1,150184 624.1%   
"Free" reserves Rs m164,3066,331 2,595.2%   
Net worth Rs m165,4576,516 2,539.4%   
Long term debt Rs m458,9631,323 34,688.5%   
Total assets Rs m868,24311,970 7,253.7%  
Interest coverage x1.915.6 12.0%   
Debt to equity ratio x2.80.2 1,366.0%  
Sales to assets ratio x0.20.9 16.9%   
Return on assets %8.47.0 121.0%  
Return on equity %16.211.8 136.6%  
Return on capital %14.012.4 112.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m04,507 0.0%   
Fx outflow Rs m3151,141 27.6%   
Net fx Rs m-3153,366 -9.4%   
CASH FLOW
From Operations Rs m-204,614886 -23,083.7%  
From Investments Rs m9,712-1,706 -569.4%  
From Financial Activity Rs m195,0331,316 14,823.5%  
Net Cashflow Rs m131497 26.4%  

Share Holding

Indian Promoters % 61.6 59.2 104.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.1 12.5 56.8%  
FIIs % 12.2 6.0 203.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.1 22.4 85.3%  
Shareholders   19,952 12,805 155.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAJAJ FINANCE With:   JSW HOLDINGS  INDIABULLS FIN. SER.  INGERSOLL RAND  COX & KINGS  COMMEX TECHNOLOGY  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

PARAG MILK FOODS LTD Plunges by 6%; BSE 500 Index Down 1.3% (Market Updates)

Sep 21, 2018 | Updated on Sep 21, 2018

PARAG MILK FOODS LTD share price has plunged by 6% and its current market price is Rs 274. The BSE 500 is down by 1.3%. The top gainers in the BSE 500 Index are ERIS LIFESCIENCES LIMITED (up 4.7%) and PHOENIX MILL (up 4.6%). The top losers are PARAG MILK FOODS LTD (down 5.8%) and BAJAJ FINANCE (down 5.3%).

The BSE HEALTHCARE Index Down 2% ; VIVIMED LABS LTD Among Top Losers (Market Updates)

Sep 21, 2018 | Updated on Sep 21, 2018

The BSE HEALTHCARE Index Down at 16,043 (down 2.0%). Among the top losers in the BSE HEALTHCARE Index today are VIVIMED LABS LTD, LINCOLN PHAR and INDOCO REMEDIES. Meanwhile, the BSE Sensex has plunged 0.7% to 37,489.

CreditAccess Grameen IPO: Should You Apply to this Interesting Microfinance Play? (IPO)

Aug 7, 2018

Should you apply to the IPO of CreditAccess Grameen Ltd?

HDFC AMC IPO: Do Valuations Leave Enough on Table for Investors? (IPO)

Jul 20, 2018

Should you subscribe to the IPO of HDFC AMC Ltd?

IndoStar Capital Finance IPO: Is This NBFC Worth Betting On? (IPO)

May 8, 2018

Should you apply for the IPO of IndoStar Capital Finance?

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BAJAJ FINANCE SHARE PRICE


Sep 21, 2018 (Close)

TRACK BAJAJ FINANCE

  • Track your investment in BAJAJ FINANCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

BAJAJ FINANCE 5-YR ANALYSIS

COMPARE BAJAJ FINANCE WITH

MARKET STATS